Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

NCT01788228 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Influenza Vaccines

Interventions

BIOLOGICAL: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (A/Indonesia)

Sponsor

GlaxoSmithKline